Max Planck Society - eDoc Server

http://edoc.mpg.de



TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Authors: Gregory, A. P.; Dendrou, C. A.; Attfield, K. E.; Haghikia, A.; Xifara, D. K.; Butter, F.; Poschmann, G.; Kaur, G.; Lambert, L.; Leach, O. A.; Promel, S.; Punwani, D.; Felce, J. H.; Davis, S. J.; Gold, R.; Nielsen, F. C.; Siegel, R. M.; Mann, M.; Bell, J. I.; McVean, G.; Fugger, L.
Date of Publication (YYYY-MM-DD): 2012-08-23
Title of Journal: Nature
Volume: 488
Issue / Number: 7412
Start Page: 508
End Page: 511
Document Type: Article
ID: 619180.0


Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies.
Authors: Krumbholz, M.; Pellkofer, H.; Gold, R.; Hoffmann, L.; Hohlfeld, R.; Kümpfel, T.
Date of Publication (YYYY-MM-DD): 2007
Title of Journal: Archives of Neurology
Volume: 64
Start Page: 1331
End Page: 1333
Document Type: Article
ID: 343259.0


Glatiramer acetate treatment in Devic's neuromyelitis optica - Reply
Authors: Gold, R.; Linington, C.
Date of Publication (YYYY-MM-DD): 2003-06
Title of Journal: Brain
Volume: 126
Start Page: E1
End Page: E1
Document Type: Article
ID: 127392.0


Devic's disease: bridging the gap between laboratory and clinic
Authors: Gold, R.; Linington, C.
Date of Publication (YYYY-MM-DD): 2002-07
Title of Journal: Brain
Volume: 125
Start Page: 1425
End Page: 1427
Document Type: Article
ID: 15217.0